欢迎来到天天文库
浏览记录
ID:53728826
大小:208.48 KB
页数:3页
时间:2020-04-20
《三维适形放疗联合紫杉醇、顺铂同步化疗对局部晚期食管癌的疗效.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、2Q生月笠3鲞筮Z期jingSUMedJ,Apri12013,V0l39,No.7●论著●三维适形放疗联合紫杉醇、顺铂同步化疗对局部晚期食管癌的疗效王达飞朱国民陈胜东蒋勤娟【摘要】目的观察三维适形放疗(3DCRT)联合紫杉醇、顺铂同步化疗治疗局部晚期食管癌的近期疗效。方法局部晚期食管癌患者56例随机均分为两组,A组采用3DCRT联合化疗,B组行单纯3DCRT治疗。比较两组的近期疗效、生存率以及不良反应。结果所有患者均获随访1年以上。A组总有效率高于B组(89.3vs.64.3)(.P<0.05)。A组1年生存率高于B组(85.7vs.67.8)(P2、5)。A组的骨髓抑制和胃肠反应发生率明显高于B组(67.9%vs.17.9和85.7%vs.25.0)(P3、ininlocallyadvancedesophagealcarcinomaWANGDafei,ZHUGuomin,CHENShengdong,eta1.DepartmentofRadiotherapy,TumourHospitalofYingxing,Yingxing214200,CHINA[Abstract]0bjectiveToevaluatetheclinicalefficacyofcombineduseof3-dimensionalconformalradiotherapy(3DCRT)andconcurrentchemotherapyofpac4、litaxelandcisplatininlocallyadvancedesophagealcarcinoma.MethodsFifty-sixpatientswithlocallyadvancedesophagealcarcinomaweretreatedwith3DCRTandconcurrentchemotherapyofpaclitaxelandcisplatin(groupA,28cases)or3DCRTalone(groupB,28cases).Theclinicalefficacywasobservedandcompared.Results5、Thepatientswerefollowedupformorethanoneyear.ThetotaleffectivenessrateofgroupAwashigherthanthatingroupB(89.3vs.64.3)(P<0.05).Sodidthe1-yearsurvivalrate(85.7vs.67.8)(P<0.05).TheincidenceratesofbonemarrowinhibitionandgastrointestinalresponsewerehigheringroupAthanthoseingroupB(67.9vs.6、17.9and85.7vs.25.O)(P7、iotherapy;ChemotherapylJiangsuMedJ,Aprif2013,39(7):827—829.1作者单位:214200江苏省,宜兴市肿瘤医院放疗科[3]FerraraA.HighBodyMassIndexbeforePrenancylinkedtoET]OngKK,DungerDB.Perfinatalgrowthfailure:theroadtoGDM[J].ObstesGynecol,2003,106(2):340.obesity,insulinresistanceandcardiovasculardiseaseinadults8、[4]JainNJ,DenkCE,KruseLK,eta1.Mat
2、5)。A组的骨髓抑制和胃肠反应发生率明显高于B组(67.9%vs.17.9和85.7%vs.25.0)(P3、ininlocallyadvancedesophagealcarcinomaWANGDafei,ZHUGuomin,CHENShengdong,eta1.DepartmentofRadiotherapy,TumourHospitalofYingxing,Yingxing214200,CHINA[Abstract]0bjectiveToevaluatetheclinicalefficacyofcombineduseof3-dimensionalconformalradiotherapy(3DCRT)andconcurrentchemotherapyofpac4、litaxelandcisplatininlocallyadvancedesophagealcarcinoma.MethodsFifty-sixpatientswithlocallyadvancedesophagealcarcinomaweretreatedwith3DCRTandconcurrentchemotherapyofpaclitaxelandcisplatin(groupA,28cases)or3DCRTalone(groupB,28cases).Theclinicalefficacywasobservedandcompared.Results5、Thepatientswerefollowedupformorethanoneyear.ThetotaleffectivenessrateofgroupAwashigherthanthatingroupB(89.3vs.64.3)(P<0.05).Sodidthe1-yearsurvivalrate(85.7vs.67.8)(P<0.05).TheincidenceratesofbonemarrowinhibitionandgastrointestinalresponsewerehigheringroupAthanthoseingroupB(67.9vs.6、17.9and85.7vs.25.O)(P7、iotherapy;ChemotherapylJiangsuMedJ,Aprif2013,39(7):827—829.1作者单位:214200江苏省,宜兴市肿瘤医院放疗科[3]FerraraA.HighBodyMassIndexbeforePrenancylinkedtoET]OngKK,DungerDB.Perfinatalgrowthfailure:theroadtoGDM[J].ObstesGynecol,2003,106(2):340.obesity,insulinresistanceandcardiovasculardiseaseinadults8、[4]JainNJ,DenkCE,KruseLK,eta1.Mat
3、ininlocallyadvancedesophagealcarcinomaWANGDafei,ZHUGuomin,CHENShengdong,eta1.DepartmentofRadiotherapy,TumourHospitalofYingxing,Yingxing214200,CHINA[Abstract]0bjectiveToevaluatetheclinicalefficacyofcombineduseof3-dimensionalconformalradiotherapy(3DCRT)andconcurrentchemotherapyofpac
4、litaxelandcisplatininlocallyadvancedesophagealcarcinoma.MethodsFifty-sixpatientswithlocallyadvancedesophagealcarcinomaweretreatedwith3DCRTandconcurrentchemotherapyofpaclitaxelandcisplatin(groupA,28cases)or3DCRTalone(groupB,28cases).Theclinicalefficacywasobservedandcompared.Results
5、Thepatientswerefollowedupformorethanoneyear.ThetotaleffectivenessrateofgroupAwashigherthanthatingroupB(89.3vs.64.3)(P<0.05).Sodidthe1-yearsurvivalrate(85.7vs.67.8)(P<0.05).TheincidenceratesofbonemarrowinhibitionandgastrointestinalresponsewerehigheringroupAthanthoseingroupB(67.9vs.
6、17.9and85.7vs.25.O)(P7、iotherapy;ChemotherapylJiangsuMedJ,Aprif2013,39(7):827—829.1作者单位:214200江苏省,宜兴市肿瘤医院放疗科[3]FerraraA.HighBodyMassIndexbeforePrenancylinkedtoET]OngKK,DungerDB.Perfinatalgrowthfailure:theroadtoGDM[J].ObstesGynecol,2003,106(2):340.obesity,insulinresistanceandcardiovasculardiseaseinadults8、[4]JainNJ,DenkCE,KruseLK,eta1.Mat
7、iotherapy;ChemotherapylJiangsuMedJ,Aprif2013,39(7):827—829.1作者单位:214200江苏省,宜兴市肿瘤医院放疗科[3]FerraraA.HighBodyMassIndexbeforePrenancylinkedtoET]OngKK,DungerDB.Perfinatalgrowthfailure:theroadtoGDM[J].ObstesGynecol,2003,106(2):340.obesity,insulinresistanceandcardiovasculardiseaseinadults
8、[4]JainNJ,DenkCE,KruseLK,eta1.Mat
此文档下载收益归作者所有